Innate immune response to influenza A virus in differentiated human alveolar type II cells.
Alveolar Type II (ATII) cells are important targets for seasonal and pandemic influenza. To investigate the influenza-induced innate immune response in those cells, we measured the global gene expression profile of highly differentiated ATII cells infected with the influenza A virus at a multiplicity of infection of 0.5 at 4 hours and 24 hours after inoculation. Infection with influenza stimulated a significant increase in the mRNA concentrations of many host defense-related genes, including pattern/pathogen recognition receptors, IFN, and IFN-induced genes, chemokines, and suppressors of cytokine signaling. We verified these changes by quantitative real-time RT-PCR. At the protein level, we detected a robust virus-induced secretion of the three glutamic acid-leucine-arginine (ELR)-negative chemokines CXCL9, CXCL10, and CXCL11, according to ELISA. The ultraviolet inactivation of virus abolished the chemokine and cytokine response. Viral infection did not appear to alter the differentiation of ATII cells, as measured by cellular mRNA and concentrations of surfactant proteins. However, viral infection significantly reduced the secretion of surfactant protein (SP)-A and SP-D. In addition, influenza A virus triggered a time-dependent activation of phosphatidylinositol 3-kinase signaling in ATII cells. The inhibition of this pathway significantly decreased the release of infectious virus and the chemokine response, but did not alter virus-induced cell death. This study provides insights into influenza-induced innate immunity in differentiated human ATII cells, and demonstrates that the alveolar epithelium is a critical part of the initial innate immune response to influenza.
Department of Medicine, National Jewish Health, 1400 Jackson St., A448, Denver, CO 80206, USA. wangj@njhealth.org
Jieru
J
Wang
Mrinalini P
MP
Nikrad
Tzulip
T
Phang
Bifeng
B
Gao
Taylor
T
Alford
Yoko
Y
Ito
Karen
K
Edeen
Emily A
EA
Travanty
Beata
B
Kosmider
Kevan
K
Hartshorn
Robert J
RJ
Mason
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002454:Cell Differentiation; D018925:Chemokines / Q000378:metabolism; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D005260:Female; D006801:Humans; D007113:Immunity, Innate; D009980:Influenza A virus / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D011650:Pulmonary Alveoli / Q000166:cytology*; D012907:Smoking; D013501:Surface-Active Agents / Q000378:metabolism
D018925:Chemokines; D013501:Surface-Active Agents; D019869:Phosphatidylinositol 3-Kinases
J Biol Chem. 2007 Aug 17;282(33):23811-7
17540762
World J Gastroenterol. 2008 Dec 21;14(47):7149-59
19084927
Apoptosis. 2007 Aug;12(8):1419-32
17468837
Virology. 2009 Sep 1;391(2):162-70
19595407
J Immunol. 2006 Aug 1;177(3):1817-24
16849492
J Immunol. 2009 Feb 1;182(3):1296-304
19155475
Respir Res. 2005 Nov 11;6:135
16283933
Respir Res. 2010 Oct 28;11:147
21029402
Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):1954-9
20133840
Virology. 2008 Mar 1;372(1):127-35
18022664
Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3455-60
19218453
J Immunol. 2008 Nov 15;181(10):7316-23
18981154
Am J Respir Cell Mol Biol. 2007 Jun;36(6):661-8
17255555
Virology. 2010 Jan 5;396(1):94-105
19880155
Am J Pathol. 2008 Sep;173(3):643-52
18669615
Curr Top Microbiol Immunol. 2007;316:233-50
17969451
Nature. 2009 Aug 20;460(7258):1021-5
19672242
J Gen Virol. 2008 Oct;89(Pt 10):2359-2376
18796704
J Virol. 2003 Apr;77(7):3898-912
12634350
Cell Microbiol. 2007 Aug;9(8):1871-9
17490408
Immunol Cell Biol. 2007 Aug-Sep;85(6):435-45
17667934
J Virol. 2008 Nov;82(22):11308-17
18684821
Proc Natl Acad Sci U S A. 2009 May 12;106(19):7945-50
19416887
J Virol. 2006 Aug;80(15):7469-80
16840327
Nat Rev Immunol. 2002 Sep;2(9):675-87
12209136
EMBO J. 2008 Dec 17;27(24):3311-21
19008854
J Virol. 2009 Sep;83(18):9486-501
19587047
Virology. 2001 Jan 20;279(2):375-84
11162793
Am J Physiol Lung Cell Mol Physiol. 2004 Feb;286(2):L382-7
14578117
Am J Pathol. 2010 Apr;176(4):1828-40
20110407
J Immunol. 2001 Jul 15;167(2):623-7
11441062
Annu Rev Immunol. 2004;22:503-29
15032587
Virology. 2003 May 10;309(2):181-9
12758165
Int Immunol. 2007 Sep;19(9):1095-102
17855433
J Infect Dis. 2009 Dec 1;200(11):1774-80
19848607
Scand J Immunol. 2004 Mar;59(3):246-54
15030574
Respir Physiol Neurobiol. 2010 Aug 31;173 Suppl:S43-54
20433956
J Immunol. 2001 Jun 15;166(12):7617-24
11390519
Nat Med. 2007 Feb;13(2):147-9
17206149
Cell Microbiol. 2006 Aug;8(8):1336-48
16882036
J Virol. 2007 Jan;81(2):860-71
17079283
Am J Physiol Lung Cell Mol Physiol. 2008 Jun;294(6):L1187-96
18375741
J Virol. 2009 Jan;83(2):836-46
18987152
Invest Ophthalmol Vis Sci. 2005 Oct;46(10):3657-65
16186347
Am J Respir Crit Care Med. 1999 May;159(5 Pt 1):1585-91
10228131
Dev Biol. 2003 Apr 1;256(1):61-72
12654292
J Gen Virol. 2007 Mar;88(Pt 3):942-950
17325368
Cell Microbiol. 2009 Jun;11(6):863-71
19290913
Nat Rev Immunol. 2007 Jun;7(6):454-65
17525754
Biol Chem. 2008 Oct;389(10):1299-305
18713015